SCHEMBL8059187

SCHEMBL8059187

CCOC(=O)[C@H](Cc1ccc(OC(=O)N2CCN(c3ccccn3)CC2)c(Cl)c1)N(C(=O)[C@H]1NC(C)(C)CS1)S(=O)(=O)c1n[nH]cc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.35
KDM4E B2RXH2 9/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 3/20 0.34
LMNA P02545 4/20 0.33
TSHR P16473 3/20 0.33
HSD17B10 Q99714 3/20 0.33
HPGD P15428 3/20 0.33
MAPT P10636 3/20 0.33
P2RX7 Q99572 1/20 0.33
SMN1; SMN2 Q16637 5/20 0.33
HTT P42858 3/20 0.33
SMO Q99835 1/20 0.33
RAB9A P51151 2/20 0.32
ADRB2 P07550 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
MITF O75030 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4413794 0.94 ALDH1A1 (0.36) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL3849517 0.89 KDM4E (0.34) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL6450077 0.83 MEN1 (0.36) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL3853401 0.83 KDM4E (0.35) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL3851010 0.83 ADRB2 (0.37) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL4449490 0.78
SCHEMBL4425462 0.74 P2RX7 (0.40) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL3850149 0.73 HSD17B10 (0.42) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL5189897 0.73 HSD17B10 (0.45) ALDH1A1KDM4EKMT2AMEN1MAPK1
SCHEMBL3851899 0.73 P2RX7 (0.38) ALDH1A1KDM4EKMT2AMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-17 EP disclosed
WO-1999006390-A1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed